{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:31:31Z","timestamp":1793050291700,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Potentially inappropriate medication (PIM) exposes patients to an increased risk of adverse outcomes. Many lists of explicit criteria provide guidance on identifying PIM and recommend alternative prescribing, but the complexity of available lists limits their applicability and the amount of data available on PIM prescribing.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine PIM prevalence and the most frequently prescribed PIMs according to 6 well-known PIM lists and to develop a best practice synthesis for clinicians.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study used anonymized electronic health record data of Swiss primary care patients aged 65 years or older with drug prescriptions from January 1, 2020, to December 31, 2021, extracted from a large primary care database in Switzerland, the FIRE project. Data analyses took place from October 2022 to September 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>PIM prescription according to PIM criteria operationalized for use with FIRE data.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcomes were PIM prevalence (percentage of patients with 1 or more PIMs) and PIM frequency (percentage of prescriptions identified as PIMs) according to the individual PIM lists and a combination of all 6 lists. The PIM lists used were the American 2019 Updated Beers criteria, the French list by Laroche et al, the Norwegian General Practice Norwegian (NORGEP) criteria, the German PRISCUS list, the Austrian list by Mann et al, and the EU(7) consensus list of 7 European countries.<\/jats:p><\/jats:sec>Results<\/jats:title>This study included 115\u202f867 patients 65 years or older (mean [SD] age, 76.0 [7.9] years; 55.8% female) with 1\u202f211\u202f227 prescriptions. Among all patients, 86\u202f715 (74.8%) were aged 70 years or older, and 60\u202f670 (52.4%) were aged 75 years or older. PIM prevalence among patients 65 years or older was 31.5% (according to Beers 2019), 15.4% (Laroche), 16.1% (NORGEP), 12.7% (PRISCUS), 31.2% (Mann), 37.1% (EU[7]), and 52.3% (combined list). PIM prevalence increased with age according to every PIM list (eg, according to Beers 2019, from 31.5% at age 65 years or older to 37.4% for those 75 years or older, and when the lists were combined, PIM prevalence increased from 52.3% to 56.7% in those 2 age groups, respectively). PIM frequency was 10.3% (Beers 2019), 3.9% (Laroche), 4.3% (NORGEP), 2.4% (PRISCUS), 6.7% (Mann), 9.7% (EU[7]), and 19.3% (combined list). According to the combined list, the 5 most frequently prescribed PIMs were pantoprazole (9.3% of all PIMs prescribed), ibuprofen (6.9%), diclofenac (6.3%), zolpidem (4.5%), and lorazepam (3.7%). Almost two-thirds (63.5%) of all PIM prescriptions belonged to 5 drug classes: analgesics (26.9% of all PIMs prescribed), proton pump inhibitors (12.1%), benzodiazepines and benzodiazepine-like drugs (11.2%), antidepressants (7.0%), and neuroleptics (6.3%).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cross-sectional study of adults aged 65 or older, PIM prevalence was high, varied considerably depending on the criteria applied, and increased consistently with age. However, only few drug classes accounted for the majority of all prescriptions that were PIM according to any of the 6 PIM lists, and by considering this manageable number of drug classes, clinicians could essentially comply with all 6 PIM lists. These results raise awareness of the most common PIMs and emphasize the need for careful consideration of their risks and benefits and targeted deprescribing.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.17988","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T15:34:43Z","timestamp":1718984083000},"page":"e2417988","source":"Crossref","is-referenced-by-count":20,"title":["Potentially Inappropriate Medication Use in Primary Care in Switzerland"],"prefix":"10.1001","volume":"7","author":[{"given":"Simeon","family":"Schietzel","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zechmann","sequence":"additional","affiliation":[{"name":"Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Rachamin","sequence":"additional","affiliation":[{"name":"Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neuner-Jehle","sequence":"additional","affiliation":[{"name":"Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Senn","sequence":"additional","affiliation":[{"name":"Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Grischott","sequence":"additional","affiliation":[{"name":"Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"issue":"1","key":"zoi240588r1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ageing\/afx147","article-title":"Potentially inappropriate medication among people with dementia in eight European countries.","volume":"47","author":"Renom-Guiteras","year":"2018","journal-title":"Age Ageing"},{"issue":"9","key":"zoi240588r2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/1060028017708394","volume":"51","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"8","key":"zoi240588r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105425","article-title":"Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization.","volume":"9","author":"Reich","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"zoi240588r4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40801-015-0035-4","article-title":"Correlation of incident potentially inappropriate medication prescriptions and hospitalization: an analysis based on the PRISCUS list.","volume":"2","author":"Henschel","year":"2015","journal-title":"Drugs Real World Outcomes"},{"issue":"2","key":"zoi240588r5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146811","article-title":"association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives.","volume":"11","author":"Endres","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"zoi240588r6","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/bcp.v83.11","article-title":"Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults.","volume":"83","author":"Varga","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"zoi240588r7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/intqhc\/mzx171","article-title":"Potentially inappropriate medication and hospitalization\/emergency department visits among the elderly in Korea.","volume":"30","author":"Jeon","year":"2018","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"zoi240588r8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/hesr.2016.51.issue-4","article-title":"Potentially inappropriate medication and health care outcomes: an instrumental variable approach.","volume":"51","author":"Chen","year":"2016","journal-title":"Health Serv Res"},{"issue":"4","key":"zoi240588r9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40266-017-0441-2","article-title":"Health Service Use, Costs, and Adverse Events Associated with Potentially inappropriate medication in old age in Germany: retrospective matched cohort study.","volume":"34","author":"Heider","year":"2017","journal-title":"Drugs Aging"},{"issue":"5","key":"zoi240588r10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.mlr.0000254571.05722.34","article-title":"Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.","volume":"45","author":"Fu","year":"2007","journal-title":"Med Care"},{"issue":"3","key":"zoi240588r11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jamda.2016.11.025","article-title":"The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies.","volume":"18","author":"Muhlack","year":"2017","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"zoi240588r12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.2019.67.issue-4","article-title":"American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults.","volume":"67","author":"2019 American Geriatrics Society Beers Criteria Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"zoi240588r13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","article-title":"Potentially inappropriate medications in the elderly: a French consensus panel list.","volume":"63","author":"Laroche","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"zoi240588r14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/02813430902992215","article-title":"The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. a modified Delphi study.","volume":"27","author":"Rognstad","year":"2009","journal-title":"Scand J Prim Health Care"},{"issue":"31-32","key":"zoi240588r15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3238\/arztebl.2010.0543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list.","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"5-6","key":"zoi240588r16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00508-011-0061-5","article-title":"Potentially inappropriate medication in geriatric patients: the Austrian Consensus Panel list.","volume":"124","author":"Mann","year":"2012","journal-title":"Wien Klin Wochenschr"},{"issue":"7","key":"zoi240588r17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries.","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"zoi240588r18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12875-017-0595-3","article-title":"General practitioners\u2019 views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients\u2014a qualitative interview study with GPs (CIM-TRIAD study).","volume":"18","author":"Pohontsch","year":"2017","journal-title":"BMC Fam Pract"},{"key":"zoi240588r20","article-title":"The FIRE project: a milestone for research in primary care in Switzerland.","volume":"140","author":"Chmiel","year":"2011","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"zoi240588r25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2.","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"zoi240588r29","doi-asserted-by":"publisher","journal-title":"BMC Public Health","DOI":"10.1186\/1471-2458-12-68"},{"issue":"14","key":"zoi240588r30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","article-title":"Explicit criteria for determining potentially inappropriate medication use by the elderly. an update.","volume":"157","author":"Beers","year":"1997","journal-title":"Arch Intern Med"},{"issue":"22","key":"zoi240588r31","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"issue":"3","key":"zoi240588r32","first-page":"385","article-title":"Defining inappropriate practices in prescribing for elderly people: a national consensus panel.","volume":"156","author":"McLeod","year":"1997","journal-title":"CMAJ"},{"issue":"11","key":"zoi240588r33","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.2015.63.issue-11","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults.","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"zoi240588r34","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","article-title":"Explicit criteria for determining inappropriate medication use in nursing home residents.","volume":"151","author":"Beers","year":"1991","journal-title":"Arch Intern Med"},{"issue":"11","key":"zoi240588r35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00228-004-0851-z","article-title":"Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study.","volume":"60","author":"Lechevallier-Michel","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"zoi240588r38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/qhc.12.3.176","article-title":"Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? the Bergen District Nursing Home (BEDNURS) study.","volume":"12","author":"Ruths","year":"2003","journal-title":"Qual Saf Health Care"},{"issue":"1","key":"zoi240588r39","doi-asserted-by":"publisher","first-page":"16774","DOI":"10.1038\/s41598-022-19860-8","article-title":"Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: a systematic review and synthesis without meta-analysis.","volume":"12","author":"Brkic","year":"2022","journal-title":"Sci Rep"},{"issue":"8","key":"zoi240588r40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis.","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi240588r41","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jama.293.11.1348","article-title":"Potentially inappropriate medication use among elderly home care patients in Europe.","volume":"293","author":"Fialov\u00e1","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"zoi240588r42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria.","volume":"74","author":"Motter","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"zoi240588r22","year":"2005","edition":"Revised Second"},{"key":"zoi240588r26","volume-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"key":"zoi240588r37","year":"2003"},{"key":"zoi240588r19","unstructured":"Elm? E, Altman? D, Egger? M, Pocock? S, Gotzsche? P, Vandenbroucke? J. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. EQUATOR Network. Accessed January 29, 2024. https:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/?"},{"key":"zoi240588r21","unstructured":"Haus\u00e4rztemangel\u2014aber mit Licht am Horizont: Workforce\u2013Studie 2020\u2014das wichtigste in K\u00fcrze. Standpunkte. Updated September 25, 2020. Accessed May 22, 2024. https:\/\/www.mfe-standpunkte.ch\/de\/ausgabe\/ausgabe-22020--43\/artikel\/hausaerztemangel-aber-mit-licht-am-horizont--76?"},{"key":"zoi240588r23","unstructured":"WHO Collaborating Centre for Drug Statistics Methology. ATC\/DDD Index 2023. Updated January 1, 2024. Accessed May 22, 2024. https:\/\/www.whocc.no\/atc_ddd_index\/?"},{"key":"zoi240588r24","unstructured":"GS1. GS1 Healthcare GTIN allocation rules standard. June 2020. Accessed May 15, 2024. https:\/\/www.gs1.org\/standards\/gs1-healthcare-gtin-allocation-rules-standard\/current-standard?"},{"key":"zoi240588r27","doi-asserted-by":"crossref","unstructured":"HCI Solutions. Compendium. Accessed May 22, 2024. https:\/\/compendium.ch","DOI":"10.1515\/9780691263274-004"},{"key":"zoi240588r28","unstructured":"Schietzel S, Zechmann S, Grischott T. Supplemental material for: potentially inappropriate medication use in primary care in Switzerland. Zenodo. 2024. Accessed May 22, 2024. https:\/\/zenodo.org\/records\/10995480?"},{"key":"zoi240588r36","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9. Pr\u00e9venir la iatrog\u00e9n\u00e8se m\u00e9dicamenteuse chez le sujet \u00e2g\u00e9. June 2005. Accessed January 29, 2024. https:\/\/archive.ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/9641eb3f4a1e67ba18a6b8aecd3f1985.pdf?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2820234\/schietzel_2024_oi_240588_1718143969.41014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T11:15:21Z","timestamp":1732274121000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2820234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.17988","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}